Antibody Generation Technologies Industry Analysed in Comprehensive La Merie Publishing Study Available at MarketPublishers.com
The Market Publishers, Ltd.Tanya RezlerTel: +44 208 144 6009Fax: +44 207 900 3970
What is the historical and present state of the art use of antibody technologies? What is the success rate of each antibody generation technology?What are the reasons for failure of antibodies in clinical development?What is the relative value of generic and of IP protected antibody technologies?What is the preferred antibody formats, IgG isotypes, development indications, parental wild-type animal species? What is the influence of the target for the success rate of the selected antibody technology? These and a lot more questions are answered in the report.
Comprehensive study prepared by La Merie Publishingprovides descriptive statistics of 504 naked antibodies and their status during January 1, 2013 to February 28, 2013. The antibodies are categorized as active during the study period or discontinued during or before the study period. Attrition rates are calculated across a number of variables:
Published: March, 2013
Price: US$ 2,765.00
More in-demandreports by La Merie Publishing can be found at